Nombre del producto:6-Hydroxy-3,4-dihydronaphthalen-1(2H)-one

IUPAC Name:6-hydroxy-1,2,3,4-tetrahydronaphthalen-1-one

CAS:3470-50-6
Fórmula molecular:C10H10O2
Pureza:95%
Número de catálogo:CM141297
Peso molecular:162.19

Unidad de embalaje Stock disponible Precio($) Cantidad
CM141297-1000g in stock Žǭij

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :3470-50-6
Fórmula molecular:C10H10O2
Punto de fusión:-
Código de sonrisas:O=C1CCCC2=C1C=CC(O)=C2
Densidad:
Número de catálogo:CM141297
Peso molecular:162.19
Punto de ebullición:358°C at 760 mmHg
Nº Mdl:MFCD00156670
Almacenamiento:Store at 2-8°C.

Category Infos

Naphthalenes
Naphthalene is a hydrocarbon produced by the distillation of coal tar and is an aromatic white crystalline substance. Naphthalene is the most abundant component in coal tar. It is used as an insect repellant and insect fumigant. The compound is used in the manufacture of celluloid, dyes, hydrogenated naphthalenes, oil fumes, smokeless powders and synthetic resins.
Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Vepdegestrant
Arvinas and Pfizer updated clinical data from a Phase 1b combination cohort evaluating vepdegestrant in combination with palbociclib. These data show that vepdegestrant plus palbociclib continue to demonstrate encouraging clinical activity in heavily pre-treated patients with a median of four lines of prior therapy with locally advanced or metastatic ER positive/human epidermal growth factor 2 – HER2 – negative breast cancer. Vepdegestrant is an investigational PROTAC ER degrader designed to harness the body’s natural protein disposal system to specifically target and degrade the estrogen receptor.